Whilst bloating typically improves as your body adjusts to treatment, targeted dietary changes, lifestyle modifications, and appropriate medical guidance can significantly reduce symptoms
A meta-regression study suggested a linear relationship between HbA1c reduction and MACE risk in patient with arGLP-1.89 Publication on mediation analyses also suggest that cardiovascular benefit could be mediated in part by effects on HbA1c, on blood pressure or reduction in urine albumin-creatinine ratio90,91 (see below), as well as by their effect on lipid profile.81 However, in subgroup analyses of cardiovascular safety studies, baseline HbA1c, weight, previous cardiovascular disease, or renal function did not predict the beneficial effects of these drugs on MACE,87 so other mechanisms, such as the previously mentioned anti-inflammatory, antifibrotic, antiatherogenic, vasodilator, or endothelial function-enhancing effects, have been suggested to influence the cardiovascular benefit of these drugs29,78 (Fig
We analyzed the annual age-standardized mortality rate of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA)
Diabetes 64 , 16881697 (2015)
GLP-1 injectable medications, such as Ozempic and Wegovy, are only available by prescription
Participant characteristics were described using mean (standard deviation) and frequencies, and compared between groups using a t-test and Chi-square test where appropriate
